<DOC>
	<DOCNO>NCT01095120</DOCNO>
	<brief_summary>Tesetaxel orally administer chemotherapy agent taxane class . This study undertaken evaluate efficacy safety tesetaxel administer second-line therapy patient advance gastric cancer .</brief_summary>
	<brief_title>Tesetaxel Second-line Therapy Patients With Advanced Gastric Cancer</brief_title>
	<detailed_description />
	<mesh_term>Adenocarcinoma</mesh_term>
	<mesh_term>Stomach Neoplasms</mesh_term>
	<criteria>Primary inclusion criterion : Confirmed diagnosis adenocarcinoma stomach esophagogastric junction Measurable disease ( revised RECIST ; Version 1.1 ) base compute tomography Eastern Cooperative Oncology Group performance status 0 1 Treatment 1 prior regimen ( firstline therapy ) regimen include fluoropyrimidine and/or platinum analogue Documented disease progression within 4 month last dose 1 prior regimen Adequate bone marrow , hepatic , renal function , define protocol At least 4 week recovery effect prior surgery therapy , include immunotherapy , radiation therapy , cytokine , biologic vaccine therapy , approve investigational agent Ability swallow oral soliddosage form medication Primary exclusion criterion : Nonmeasurable disease ( revised RECIST ; Version 1.1 ) History presence brain metastasis leptomeningeal disease Operable gastric cancer operable cancer esophagogastric junction Uncontrolled diarrhea , define 3 loose bowel movement patient 's usual number bowel movement least 2 day within 14 day prior enrollment Uncontrolled nausea vomit within 14 day prior enrollment despite administration standard antiemetic therapy Known malabsorptive disorder Significant medical disease cancer , define protocol Presence neuropathy &gt; Grade 1 ( National Cancer Institute Common Toxicity Criteria [ NCI CTC ] ; Version 4.0 ) Prior treatment taxane tubulintargeted agent ( eg , indibulin ) vinca alkaloid Need continue regularlytaken medication potent inhibitor inducer CYP3A pathway Pglycoprotein activity</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2012</verification_date>
</DOC>